在扶手椅石墨烯纳米带异构结构中的拓接口状态和非线性热电性能
1Department of Electrical Engineering and Department of Physics, National Central University Chungli 32001 Taiwan mtkuo@ee.ncu.edu.tw.
RSC advances
|January 23, 2026
概括
在扶手椅中界面状态石墨烯纳米带异构结构形成拓双量子点. 这些结构表现出增强的热电输出功率,特别是在强大的库伦相互作用下,为先进的电子设备提供了潜力.
科学领域:
- 凝聚物质物理学 凝聚物质物理学
- 材料科学 材料科学 材料科学
- 纳米技术 纳米技术
背景情况:
- 扶手椅石墨烯纳米带异构结构 (AGNRHs) 缺乏转换对称性,从而产生独特的电子特性.
- AGNR中的接口状态 (IF) 和终端状态 (ES) 对于理解它们的电子行为至关重要.
研究的目的:
- 调查AGNRH中IF的出现和拓性质.
- 将IF与构成AGNR细分市场的ES联系起来.
- 探索AGNRH作为热电应用的拓双量子点 (TDQD) 的潜力.
主要方法:
- 现实空间散量边界扰动方法来分析IF杂交.
- 斯特克效应分析以分离ES和IF.
- 安德森模型使用库伦相互作用来导出道电流.
- 热电分析用于评估输出功率.
主要成果:
- AGNRH中的IF是由外部和中心部分之间的ES差异决定的,而chirality是由这种差异决定的.
- 当IF来源于AGNR中部部门ES时,AGNRHs托管TDQDs.
- TDQD显示在稀释电荷状态下增强的非线性热电输出功率,库伦阻塞影响电流超过电压.
结论:
- AGNRH可以托管形成TDQD的拓保护IF.
- TDQD提供了显著的非线性热电功率增强,即使在强大的电子与电子相互作用.
- 这些发现表明纳米级热电器件的潜在应用.
相关概念视频
Nonlinear Pharmacokinetics: Causes of Nonlinearity
719
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
719
Protein-protein Interfaces
14.6K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.6K
Protein-Protein Interfaces
4.4K
4.4K
Nonlinear Pharmacokinetics: Overview
1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
Nonlinear Pharmacokinetics: Michaelis-Menten Equation
1.1K
The Michaelis–Menten equation is a fundamental model for describing capacity-limited kinetics in drug metabolism. It offers insights into the rate of decline of plasma drug concentration Cp over time, with Vmax and KM as pivotal parameters.
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
Vmax represents the maximum achievable process rate, while KM, known as the Michaelis constant, signifies the drug concentration at which the process rate reaches half its maximum. This relationship between Vmax, KM, and Cp gives rise to three distinct...
1.1K
Nonlinear Pharmacokinetics: Role of Transporters
288
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
288


